We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.57%
AUM
$2.66T
AUM Growth
+$109B
Cap. Flow
+$23.2B
Cap. Flow %
0.87%
Top 10 Hldgs %
15.37%
Holding
4,245
New
126
Increased
2,532
Reduced
1,280
Closed
76

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$3.23B
2
CTVA icon
Corteva
CTVA
+$1.64B
3
NEM icon
Newmont
NEM
+$1.04B
4
MSFT icon
Microsoft
MSFT
+$981M
5
ALC icon
Alcon
ALC
+$794M

Sector Composition

Rank Sector Weight
1 Technology 17.43%
2 Financials 15.04%
3 Healthcare 12.95%
4 Consumer Discretionary 10.13%
5 Industrials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VISL
4151
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$18K ﹤0.01%
95
TENX icon
4152
Tenax Therapeutics
TENX
$363M
$17K ﹤0.01%
8
ATIS
4153
DELISTED
Attis Industries Inc. Common Stock
ATIS
$17K ﹤0.01%
10,309
FABC
4154
Fabric.AI Inc
FABC
$16.6M
$16K ﹤0.01%
22
OPGN
4155
DELISTED
OpGen, Inc
OPGN
$16K ﹤0.01%
10
BDR
4156
DELISTED
Blonder Tongue Laboratories Inc
BDR
$16K ﹤0.01%
16,400
EMMA
4157
DELISTED
Emmaus Life Sciences, Inc. Common Stock
EMMA
$16K ﹤0.01%
2,024
+74
+4% +$549
BSIN
4158
Big Sky Industrial
BSIN
$59.6M
$13K ﹤0.01%
2,834
OLOX
4159
Olenox Industries
OLOX
$6.74M
0
UAVS icon
4160
AgEagle Aerial Systems
UAVS
$40.9M
$11K ﹤0.01%
37
XTIA icon
4161
XTI Aerospace
XTIA
$57.3M
0
PHIO icon
4162
Phio Pharmaceuticals
PHIO
$11.8M
$10K ﹤0.01%
4
TOVX icon
4163
Theriva Biologics
TOVX
$9.64M
$10K ﹤0.01%
73
-156
-68% -$22.4K
AIRTW
4164
DELISTED
Air T Inc Warrants
AIRTW
$10K ﹤0.01%
+141,066
New +$15K
GPUS
4165
Hyperscale Data Inc
GPUS
$55.4M
0
SCON
4166
DELISTED
Superconductor Technologies Inc.
SCON
$8K ﹤0.01%
1,009
NURO
4167
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$5K ﹤0.01%
149
SINT icon
4168
SiNtx Technologies
SINT
$10.8M
0
BAK icon
4169
Braskem
BAK
$928M
-1,064,065
Closed -$27.5M
BLIN icon
4170
Bridgeline Digital
BLIN
$14.6M
-1,113
Closed -$9K
CETX icon
4171
Cemtrex
CETX
$4.25M
0
-$36K
CYD icon
4172
China Yuchai International
CYD
$1.77B
-11,946
Closed -$190K
EVGN icon
4173
Evogene
EVGN
$5.7M
-6,352
Closed -$116K
FENC icon
4174
Fennec Pharmaceuticals
FENC
$332M
-45,067
Closed -$219K
HEPA
4175
DELISTED
Hepion Pharmaceuticals
HEPA
-1
Closed -$23K

Similar funds

Vanguard Group's Q2 2019 Portfolio in Review

As of Q2 2019, Vanguard Group held 4,245 positions worth $2.66T, up 4.3% from $2.55T the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 4.8%. Vanguard Group opened 126 new positions and exited 76, leaving the 4,245-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard Group's largest Q2 2019 buy was Dow Inc: 61,095,269 shares worth $3.01B.
  • Vanguard Group added most to Newmont in Q2 2019, an estimated $1.04B increase.
  • Vanguard Group's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $2.79B.
  • Vanguard Group fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $922M.
  • Vanguard Group's ten largest holdings make up 15% of its $2.66T portfolio in Q2 2019.
  • Vanguard Group opened 126 new positions and closed 76 in Q2 2019.
  • Vanguard Group's portfolio value rose 4.3% quarter-over-quarter to $2.66T.

Based on Vanguard Group's 13F filing for Q2 2019, filed 14 Aug 2019.